# Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

> **NCT01700790** · PHASE4 · TERMINATED · sponsor: **University of Miami** · enrollment: 9 (actual)

## Conditions studied

- AIDS
- Tuberculosis

## Interventions

- **DRUG:** Lopinavir/ritonavir and ritonavir

## Key facts

- **NCT ID:** NCT01700790
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2018-11-17
- **Final completion:** 2018-12-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** No Further Funding
- **Last updated:** 2019-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01700790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01700790, "Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01700790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*